Polyrizon completes branding process for PL-14 allergy blocker

Polyrizon (PLRZ) completed the branding process for its PL-14 allergy blocker, which will be marketed under the brand name NASARIX. NASARIX is based on Polyrizon’s proprietary Capture and Contain hydrogel technology, an innovative intranasal spray formulation designed to create a protective physical barrier against allergens and viruses. As part of the branding process, Polyrizon conducted comprehensive trademark screening and linguistic evaluations across the U.S. and European markets to support brand viability and alignment with regulatory and market requirements. Polyrizon expects NASARIX to be introduced in alignment with its ongoing clinical progress and regulatory pathway.